Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Oct 14;8:381–387. doi: 10.2147/CLEP.S113211

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 Christensen et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Annual prevalence of all glucose-lowering drug-users (A) and insulin users (B) in Denmark per 1,000 inhabitants, 1999–2014.

Notes: The number of persons prescribed different therapies in a given year is higher than the total number of glucose-lowering drug users that year due to possibility of polypharmacy and drug shifters. Mixed insulin cover insulin preparations consisting of intermediate- or long-acting insulin in combination with fast-acting insulin.

Abbreviations: GLP-1, glucagon-like peptide 1; DPP-4, dipeptidylpeptidase 4; SGLT-2, sodium–glucose cotransporter 2.